Observational analyses from ADVANCE and ADVANCE-ON.
John ChalmersMark WoodwardPublished in: Diabetes, obesity & metabolism (2021)
Embedding post-randomization and epidemiological analyses into clinical trials is worthwhile and can be highly productive in advancing scientific knowledge.